VistaGen Therapeutics (VTGN)
(Delayed Data from NSDQ)
$3.02 USD
+0.10 (3.42%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $3.03 +0.01 (0.33%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.40 |
EPS Last Quarter | -0.35 |
Last EPS Surprise | 14.63% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.79 |
Next Year | -1.85 |
EPS (TTM) | -1.48 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.34M | 0.34M | 0.69M | 0.88M |
# of Estimates | 2 | 2 | 3 | 1 |
High Estimate | 0.57M | 0.57M | 1.66M | 0.88M |
Low Estimate | 0.10M | 0.10M | 0.10M | 0.88M |
Year ago Sales | 0.28M | 0.41M | 1.06M | 0.69M |
Year over Year Growth Est. | 19.64% | -18.29% | -35.45% | 28.24% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.40 | -0.48 | -1.79 | -1.85 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -0.39 | -0.48 | -1.80 | -1.39 |
High Estimate | -0.39 | -0.48 | -1.78 | -1.39 |
Low Estimate | -0.41 | -0.48 | -1.80 | -2.58 |
Year ago EPS | -0.66 | -0.22 | -1.52 | -1.79 |
Year over Year Growth Est. | 39.39% | -118.18% | -17.76% | -3.35% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Current | -0.40 | -0.48 | -1.79 | -1.85 |
7 Days Ago | -0.40 | -0.48 | -1.79 | -1.85 |
30 Days Ago | -0.40 | -0.48 | -1.79 | -1.85 |
60 Days Ago | -0.40 | -0.48 | -1.79 | -1.85 |
90 Days Ago | -0.52 | -0.60 | -2.08 | -2.11 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.40 | -0.48 | -1.79 | -1.85 |
Zacks Consensus Estimate | -0.40 | -0.48 | -1.79 | -1.85 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.35 | -0.25 | -0.22 | -0.66 | NA |
Estimate | -0.41 | -0.34 | -0.31 | NA | NA |
Difference | 0.06 | 0.09 | 0.09 | NA | 0.08 |
Surprise | 14.63% | 26.47% | 29.03% | NA | 23.38% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more